2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosusRecruitingNot stated2026-09-21NCT07330245
Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-negative and PD-L1 TAP Score of 5 or More Advanced Gastroesophageal Adenocarcinomagastroesophageal adenocarcinomaNot yet recruitingPhase 32026-08-18NCT07763171